Financial News Feed

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 7) Akero Therapeutics Inc (NASDAQ: AKRO ) Allakos Inc (NASDAQ: ALLK ) Cytokinetics, Inc. (NASDAQ: CYTK ) Guardant Health Inc (NASDAQ: GH ) (reacted to strong second-quarter results) Morphic Holding Inc (NASDAQ: MORF ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 7) ABIOMED, Inc. (NASDAQ: ABMD ) Assertio Therapeutics Inc (NASDAQ: ASRT ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) Bicycle Therapeutics PLC (NASDAQ: BCYC ) BioCardia Inc (NASDAQ: BCDA ) BIOLINERX LTD/S ADR (NASDAQ: BLRX ) Biopharmx Corp NYSE: (BPMX) CAN-FITE BIOPHA/S ADR (NYSE: CANF ) CELLECT BIOTECH/S ADR (NASDAQ: APOP ) Cellular Biomedicine Group Inc (NASDAQ: CBMG )(reacted to second-quarter results) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX )(reported second-quarter results) Guardion Health Sciences Inc (NASDAQ: GHSI )(announced common stock offering of 9.

Read more

Abiomed (ABMD) Q1 Earnings Beat Estimates
12:45pm, Thursday, 01'st Aug 2019
Abiomed (ABMD) delivered earnings and revenue surprises of 1.01% and -1.38%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Read more

ABIOMED's (ABMD) flagship Impella receives a slew of regulatory approvals.

Read more

Abiomed (ABMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Read more

ABIOMED (ABMD) receives the FDA confirmation of the safety and effectiveness of the company's Impella RP heart pump.

Read more

https://www.investing.com/analysis/abiomed-abmd-to-launch-impella-cp-with-smartassist-at-scai-200422971

Read more

ABIOMED's (ABMD) FDA-approved Impella 2.5 and Impella CP treat certain advanced heart failure patients.

Read more

The FDA approves the use of Abiomed's ([[ABMD]] -3.6%) Impella 5.0 and Impella LD heart pumps for the treatment of cardiogenic shock for up to 14 days (fro

Read more

ABMD earnings call for the period ending March 31, 2019.

Read more

Abiomed, Inc. (NASDAQ:ABMD) Q1 2019 Earnings Conference Call May 02, 2019, 08:00 ET Company Participants Ingrid Ward - Director, IR Michael Minogue - Chairman,

Read more

ABMD, FLR and W among premarket losers
01:13pm, Thursday, 02'nd May 2019

Read more

Abiomed (ABMD) Matches Q4 Earnings Estimates
12:25pm, Thursday, 02'nd May 2019
Abiomed (ABMD) delivered earnings and revenue surprises of 0.00% and -4.89%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Read more

Abiomed beats by $0.50, misses on revenue
11:05am, Thursday, 02'nd May 2019
Abiomed (ABMD): Q4 GAAP EPS of $1.60 beats by $0.50. Revenue of $207.08M (+18.7% Y/Y) misses by $11.8M. Press Release

Read more

Proudly made at

ROCKIT